Investment Analysts’ Updated EPS Estimates for August 13th (AMRQ, ARX, AVBP, AVEX, BBY, BETA, BTSG, CADL, CBRS, CRM)

Investment Analysts’ updated eps estimates for Thursday, August 13th:

Amaroq Minerals (LON:AMRQ) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 140 target price on the stock.

Accelerant (NYSE:ARX) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

ArriVent BioPharma (NASDAQ:AVBP) had its buy rating reiterated by analysts at Guggenheim. They currently have a $45.00 target price on the stock.

ArriVent BioPharma (NASDAQ:AVBP) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $42.00 target price on the stock.

AEVEX (NYSE:AVEX) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $45.00 target price on the stock.

Balfour Beatty (LON:BBY) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 985 target price on the stock.

BETA Technologies (NYSE:BETA) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $33.00 price target on the stock.

BETA Technologies (NYSE:BETA) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $31.00 price target on the stock.

BrightSpring Health Services (NASDAQ:BTSG) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $90.00 target price on the stock.

Candel Therapeutics (NASDAQ:CADL) had its buy rating reissued by analysts at HC Wainwright. They currently have a $23.00 price target on the stock.

Cerebras Systems (NASDAQ:CBRS) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $300.00 target price on the stock.

JPMorgan Chase & Co. began coverage on shares of Salesforce (NYSE:CRM). They issued an overweight rating and a $250.00 target price on the stock.

Oppenheimer Holdings, Inc. assumed coverage on shares of Carriage Services (NYSE:CSV). The firm issued an outperform rating and a $48.00 target price on the stock.

Journey Medical (NASDAQ:DERM) had its buy rating reissued by analysts at B. Riley Financial, Inc.. They currently have a $15.00 price target on the stock, up from their previous price target of $12.00.

Enersys (NYSE:ENS) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $280.00 target price on the stock.

Entain (LON:ENT) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 1,000 price target on the stock.

Enovix (NASDAQ:ENVX) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $25.00 price target on the stock.

HBT Financial (NASDAQ:HBT) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $41.00 price target on the stock, up from their previous price target of $38.00.

Harmonic (NASDAQ:HLIT) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $20.00 price target on the stock.

Korea Electric Power (NYSE:KEP) was downgraded by analysts at Nomura from a buy rating to a neutral rating.

Canaccord Genuity Group Inc. assumed coverage on shares of Novogen (NASDAQ:KZIA). The firm issued a buy rating and a $29.00 price target on the stock.

Liftoff Mobile (NASDAQ:LFTO) had its buy rating reissued by analysts at BTIG Research. They currently have a $35.00 price target on the stock.

Light Science Technologies (LON:LST) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.

Petro Matad (LON:MATD) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Marks and Spencer Group (LON:MKS) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 435 price target on the stock.

Alliance Global Partners assumed coverage on shares of Momentus (NASDAQ:MNTS). Alliance Global Partners issued a buy rating and a $8.00 target price on the stock.

Benchmark Co. started coverage on shares of MACOM Technology Solutions (NASDAQ:MTSI). Benchmark Co. issued a buy rating and a $375.00 target price on the stock.

Nebius Group (NASDAQ:NBIS) had its neutral rating reissued by analysts at DA Davidson. They currently have a $175.00 target price on the stock.

Nexxen International (NASDAQ:NEXN) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $16.00 target price on the stock.

Raymond James Financial, Inc. started coverage on shares of Polaryx Therapeutics (NASDAQ:PLYX). The firm issued a strong-buy rating and a $6.00 price target on the stock.

Lake Street Capital started coverage on shares of RF Industries (NASDAQ:RFIL). They issued a buy rating and a $19.00 price target on the stock.

The Rank Group (LON:RNK) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Runway Growth Finance (NASDAQ:RWAY) had its buy rating reissued by analysts at B. Riley Financial, Inc.. They currently have a $11.00 target price on the stock, up from their previous target price of $10.00.

Spotify Technology (NYSE:SPOT) had its buy rating reiterated by analysts at Argus. Argus currently has a $600.00 price target on the stock.

Secure Trust Bank (LON:STB) had its house stock rating reissued by analysts at Shore Capital Group Ltd. They currently have a GBX 2,300 target price on the stock, up from their previous target price of GBX 2,200.

Sutro Biopharma (NASDAQ:STRO) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $60.00 target price on the stock.

STUB (NYSE:STUB) had its underperform rating reaffirmed by analysts at Bank of America Corporation. Bank of America Corporation currently has a $7.50 price target on the stock, down from their previous price target of $11.00.

Bio-Techne (NASDAQ:TECH) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. They currently have $73.00 target price on the stock.

Trimble (NASDAQ:TRMB) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $87.00 target price on the stock.

Tronox (NYSE:TROX) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. JPMorgan Chase & Co. currently has $5.00 target price on the stock, down from their previous target price of $7.00.

Zegona Communications (LON:ZEG) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 2,200 target price on the stock.